About Biomotum
Biomotum is a company based in Flagstaff (United States) founded in 2019 by Joseph Lerner, Zach Lerner, and Ray Browning. Biomotum has raised $660 thousand across 3 funding rounds from investors including HHS. Biomotum offers products and services including Biomotum SPARK and Robotic Ankle Assist Device. Biomotum operates in a competitive market with competitors including Ekso Bionics, Otto Bock, Myomo, Wandercraft and Proteor, among others.
- Headquarter Flagstaff, United States
- Founders Joseph Lerner, Zach Lerner, Ray Browning
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomotum, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$660 K (USD)
in 3 rounds
-
Latest Funding Round
$274.28 K (USD), Grant
Jul 12, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomotum
Biomotum offers a comprehensive portfolio of products and services, including Biomotum SPARK and Robotic Ankle Assist Device.
Assists walking for rehabilitation and daily mobility needs.
Provides assistance for clinical trials and human ambulation studies.
People of Biomotum
Unlock access to complete
Unlock access to complete
Funding Insights of Biomotum
Biomotum has successfully raised a total of $660K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $274.28 thousand completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biomotum
Biomotum has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Biomotum
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomotum
Investment portfolio details for Biomotum
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biomotum
Detailed financials for Biomotum
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomotum Comparisons
Peer comparison for Biomotum
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomotum
Biomotum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ekso Bionics, Otto Bock, Myomo, Wandercraft and Proteor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Exoskeletons for medical rehabilitation and industrial productivity are provided.
|
|
| Locked | Locked | Locked |
Prosthetic and orthotic devices are developed for individuals with disabilities.
|
|
| Locked | Locked | Locked |
Robotic arms are provided for mobility and rehabilitation support.
|
|
| Locked | Locked | Locked |
Exoskeleton devices are provided for rehabilitation patients' mobility.
|
|
| Locked | Locked | Locked |
Prostheses and orthoses devices are developed for orthopedic supports.
|
|
| Locked | Locked | Locked |
Lightweight exoskeletons are developed to assist walking for mobility-impaired users.
|
Detailed competitors of Biomotum
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomotum
Complete news archive for Biomotum
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomotum
Biomotum was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Biomotum is headquartered in Flagstaff, United States. It is registered at Flagstaff, Arizona, United States.
Ray Browning is the current CEO of Biomotum. They have also founded this company.
Biomotum is a funded company, having raised a total of $660K across 3 funding rounds to date.
Biomotum was founded in 2019 and is based in Flagstaff, United States. Robotic assistive devices are produced by the company for children and adults affected by movement disorders. These devices support mobility through enhancements in coordination, reductions in walking energy expenditure, increases in walking speed, and improvements in leg strength. Operations focus on the health technology sector, with devices designed for therapeutic applications.
Biomotum's top competitors include Otto Bock, Myomo and Ekso Bionics.
Biomotum offers Biomotum SPARK and Robotic Ankle Assist Device.
Biomotum has 1 investor. Key investors include HHS.